BMYMP News and Press, Bristol-Myers Squibb $2Pr From 06/30/23

2023-06-30 14:38:56 ET Summary Evotec SE caught a 34% bid over the last 6 months. Despite growth in customers and R&D partnerships, further clarifications are needed for the investor to avoid buying on speculation. Whilst emerging trends in the firm's operations are constr...

2023-06-23 09:15:00 ET Summary This monthly series ranks a selection of dividend growth stocks in Dividend Radar and presents the ten top-ranked stocks for consideration and possible investment. The stocks were selected based on quality, safety, valuation, and yield/growth criteri...

2023-06-13 14:55:23 ET Bristol-Myers Squibb Company (BMY) Goldman Sachs 44th Annual Global Healthcare Conference June 13, 2023 11:40 AM ET Company Participants Lynelle Hoch - SVP, Global Cell Therapy Franchise Roland Chen - SVP, Cardiovascular Development Confe...

2023-06-08 23:21:36 ET Summary The article analyzes Amgen's financial performance, including balance sheet trends, valuation models, and competition & margin trends. We'll discuss AMGN's dividend and free cash flow of this large, very well-covered dividend growth stock. Am...

2023-06-08 12:30:05 ET Bristol-Myers Squibb Company (BMY) Jefferies Healthcare Conference June 08, 2023 09:00 AM ET Company Participants Adam Lenkowsky - Chief Commercialization Officer Conference Call Participants Akash Tewari - Jefferies Presentation ...

2023-06-06 14:02:06 ET Bristol-Myers Squibb Company (BMY) 2023 Virtual ASCO Investor Event Conference June 06, 2023 08:00 AM ET Company Participants Tim Power - Investor Relations Samit Hirawat - Chief Medical Officer Adam Lenkowsky - Chief Commercialization Offi...

2023-05-31 09:47:21 ET Summary Geron Corporation's imetelstat has shown a clear benefit in treating lower-risk myelodysplastic syndromes (LR-MDS), with positive results in its phase 3 IMerge study. Imetelstat is likely to receive FDA approval for LR-MDS, with a potential priority ...

2023-05-16 01:29:25 ET Summary GSK's operating income margin in Q1 2023 was 29.35%, showing an increase in the previous quarter and the last year. Vaccine sales were $2,493 million in Q1 2023, up 11.9% year-over-year, mainly due to Fluarix and FluLaval, which regulators approved t...

2023-05-08 13:32:43 ET Summary WisdomTree U.S. Value Fund ETF is an actively managed fund focused on dividends, buybacks and quality. It is well-diversified across sectors and holdings. The portfolio is greatly superior to the benchmark in valuation, and to a lesser extent in ...

2023-04-28 18:25:06 ET Summary AbbVie's revenue amounted to $12,225 million in the first three months of 2023, 9.7% less than the previous year. US sales of Humira were $2,948 million, down 41.1% quarter-on-quarter and 26.2% year-over-year. In addition to unsuccessful drug sal...